The breast cancer risk assessment test that detected Olivia Munn's aggressive Luminal B cancer has now identified breast ...

The TCR report forecasts that by 2032 prostate cancer will increase steadily and remain the number one cancer of concern ...

A routine eye appointment led to the discovery of a rare cancer for a Hampshire woman. Lynsey Schulkins, 43, first noticed ...

Mary Beckerle is stepping down from her long tenure as CEO of Huntsman Cancer Institute at the University of Utah. Beckerle ...

Teclistamab-cqyv is a T-cell-engaging bispecific antibody that targets multiple myeloma cells via the B-cell maturation ...

Researchers discovered how to flip the structure of complex drug compounds using a simple reagent, offering a game-changing ...

The hunt for a medical breakthrough has been caught up in the Trump administration's political assault on the university.

Revolution Medicines' proprietary data will train a bespoke version of NeuralPLexer, an AI model for protein-ligand ...

A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI.

A new study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center may help explain why certain liver ...

A fundamental discovery by University of Missouri scientists could help solve one of the most frustrating challenges in ...

Recent research on MCL-1, a critical protein that is an attractive target for cancer drug development, helps explain why some ...